Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial.

Satoshi OkumuraMikiya IshiharaNaomi KiyotaKimikazu YakushijinKohichi TakadaShinichiro KobayashiHiroaki IkedaMakoto EndoKoji KatoShigehisa KitanoAkihiko MatsumineYasuhiro NagataShinichi KageyamaTaizo ShiraishiTomomi YamadaKeizo HoribeKazuto TakesakoHiroshi MiwaTakashi WatanabeYoshihiro MiyaharaHiroshi Shiku

Published in: BMJ open (2022)

jRCT2043210077.

Keyphrases

clinical trial
papillary thyroid
randomized controlled trial
squamous cell
cancer therapy
locally advanced
study protocol
open label
liver metastases
lymph node metastasis
bone marrow
drug delivery
phase iii
radiation therapy